77 results
Page 3 of 4
6-K
EX-99.1
b7v9v4qzze
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.1
d4wtgstx95crz2
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
424B4
ewbpqiv
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
npxcbic6 i5
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
48w1q me8
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.1
jw8pr
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
1ygl5y
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.2
127ovrzs6pg7dqo7 4y
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1
vwl0 kwxsq52
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.1
d6a49bmncaro
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am
6-K
EX-99.2
ojhfqxdlxkn6opnyh4
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
1dgfhkvje rsqfhpq
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
2tqpluc5su 46
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
1n9jai7qg44rwyoldfh
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
41p6ctt
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
ax77k7vru 6dy8ku4sz0
19 Mar 20
Registration statement (foreign) (amended)
12:21pm